Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$11,247,056
+$2,542,353 QoQ
Shares Held
9,377
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#1,197
of 4,621 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $33,612,604 across 12 Drug Manufacturers - General names. LLY ranks #1 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,377 | $11,247,056 | |
| 2 | ABBV |
AbbVie Inc.
|
22,380 | $5,631,703 | |
| 3 | JNJ |
Johnson & Johnson
|
20,128 | $5,111,908 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,013 | $3,728,170 | |
| 5 | PFE |
Pfizer Inc
|
94,107 | $2,266,096 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
34,471 | $1,986,219 | |
| 7 | AMGN |
Amgen Inc
|
4,406 | $1,595,500 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,409 | $809,713 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,247,056 | 9,377 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,704,703 | 9,464 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,940,811 | 7,389 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,962,729 | 3,883 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,086,159 | 3,959 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,786,797 | 4,585 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,185,784 | 5,422 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,390,718 | 4,956 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $4,088,696 | 4,516 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,625,293 | 4,660 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,769,452 | 4,751 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,083,527 | 3,879 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,579,524 | 3,368 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $966,727 | 2,815 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,066,423 | 2,915 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $952,265 | 2,945 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $957,621 | 3,344 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,067,866 | 3,866 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $951,232 | 4,117 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $960,311 | 4,184 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $746,345 | 3,995 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $655,268 | 3,881 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $698,210 | 4,717 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $743,407 | 4,528 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $555,573 | 4,005 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||